« Previous
Next »
Titles
- IRB waiver or alteration of informed consent for clinical investigations involving no more than minimal risk to human subjects: guidance for sponsors, investigators, and institutional review boards1
- Implementation of acceptable full-length and abbreviated donor history questionnaires and accompanying materials for use in screening donors of blood and blood components: guidance for industry1
- Industrial hygiene problems in Bolivia, Peru, and Chile1
- Infant formula enforcement discretion policy: guidance for industry1
- Informed consent. Guidance for IRBs, clinical investigators, and sponsors1
- Institutional review board (IRB) review of individual patient expanded access submissions for investigational drugs and biological products: guidance for IRBs and clinical investigators1
- Instructions for use: patient labeling for human prescription drug and biological products : content and format1